(18)F-FDG PET-CT for the prediction of mortality in patients with dermatomyositis and without malignant tumors: a pilot study

BACKGROUND: (18)F-fluorodeoxyglucose positron emission tomography-computed tomography ((18)F-FDG PET-CT) is typically used to screen malignancy in patients with dermatomyositis (DM). The aim of this study was to investigate the value of using PET-CT in assessing the prognosis of patients with DM and...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Yiduo, Wang, Bing, Zhang, Feifei, Wu, Min, Wang, Dongyan, Shao, Xiaoliang, Shao, Xiaonan, Wang, Jianfeng, Liu, Bao, Shi, Yunmei, Yu, Wenji, Wang, Yuetao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239996/
https://www.ncbi.nlm.nih.gov/pubmed/37284117
http://dx.doi.org/10.21037/qims-22-1174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239996/
https://www.ncbi.nlm.nih.gov/pubmed/37284117
http://dx.doi.org/10.21037/qims-22-1174

Ejemplares similares